NASDAQ · Medical - Devices

GBS Inc. (GBS) Stock

$0.47 -1.58% NASDAQ: GBS Healthcare

Operating across North America and the Asia-Pacific region, GBS Inc. specializes in biosensor diagnostic technology.

Valuation

MetricValue
Price$0.47
Market Cap$433577
P/E Ratio-0.18
P/B Ratio0.41
P/S Ratio0.38
EPS (TTM)$-2.00
52-Week High$2.89
52-Week Low$0.36
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-174.16%
ROA-78.13%
ROCE-114.61%
Gross Margin32.08%
Operating Margin-300.26%
Net Margin-296.76%
Debt/Equity0.21
Current Ratio2.11

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.0M$0$1.0M$3.0M$3.0M
Operating Profit$-6.0M$-8.0M$-13.0M$-10.0M$-11.0M
Net Profit$-7.0M$-8.0M$-11.0M$-10.0M$-11.0M
EPS$-0.52$-0.57$-10.58$-6.10$-2.00
Op Margin-281.4%-1907.1%-1002.1%-330.5%-348.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$22.0M$12.0M$10.0M$14.0M$8.0M
Total Liabilities$7.0M$6.0M$7.0M$6.0M$5.0M
Cash$13.0M$8.0M$2.0M$6.0M$1.0M
Borrowings$0$0$1.0M$1.0M$0

Latest News

What NYC artist says about coming Charlie Kirk statue USA TODAY · Jul 16, 2026 Bitcoin and ethereum prices today, Thursday, July 16, 2026: Prices rise, ethereum becomes 'increasingly compelling' Yahoo Personal Finance · Jul 16, 2026 Deutsche Bank Adjusts Price Target on Denali Therapeutics to $35 From $31, Maintains Buy Rating MT Newswires · Jul 16, 2026 BofA Securities Upgrades Cintas to Buy From Neutral, Raises Price Target to $230 From $200 MT Newswires · Jul 16, 2026 Checkers & Rally’s Franchisee Buys 10 Stores in Alabama and Mississippi Markets QSR · Jul 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-11.0M$-3.0M$-7.0M$-10.0M$-10.0M
Investing Cash Flow$0$-1.0M$-1.0M$0$0
Financing Cash Flow$23.0M$0$1.0M$11.0M$5.0M
Net Cash Flow$12.0M$-4.0M$-7.0M$5.0M$-5.0M
Free Cash Flow$-11.0M$-4.0M$-7.0M$-10.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.34
FCF Yield-770.28%
Quick Ratio1.98
Interest Coverage-157.90
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BIOCBiocept, Inc. $0.43 +0.00% -0.01 $450786 0.00%
BIOLBIOLASE, Inc. $0.02 +27.39% 0.00 $731942 0.00%
LFLYLeafly Holdings, Inc. $37.00 +0.00% -16.09 $114.90M 0.00%
OSAProSomnus, Inc. $0.47 +0.00% -0.32 $8.18M 0.00%
OTRKOntrak, Inc. $0.33 +358.19% -0.06 $2.34M 0.00%

About GBS Inc.

Operating across North America and the Asia-Pacific region, GBS Inc. specializes in biosensor diagnostic technology. Its key product is the Saliva Glucose Biosensor, an innovative organic thin-film transistor designed for diabetes management that quantifies glucose levels directly from saliva. The company is also actively advancing a SARS-CoV-2 Biosensor, intended as a supplementary diagnostic tool to existing RNA virus detection tests, and is constructing a broad biosensor platform covering diagnostic modalities such as biochemistry, immunology, tumor markers, hormones, and nucleic acids. GBS Inc. maintains a research agreement with the Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic solutions. Founded in 2016 and headquartered in New York, New York, the company adopted its current name, GBS Inc., in September 2019, having previously operated as Glucose Biosensor Systems (Greater China) Holdings, Inc. It operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

GBS Inc. is headquartered in US.

GBS Inc. (GBS) stock trades at $0.47 with a market capitalization of $433577. The stock is valued at a price-to-earnings (P/E) ratio of -0.18, price-to-book of 0.41, price-to-sales of 0.38. Over the past 52 weeks the stock has ranged between $0.36 and $2.89, and currently trades 83.7% below its 52-week high.

On profitability, GBS Inc. generates a return on equity (ROE) of -174.16%, return on capital employed of -114.61%, an operating margin of -300.26%, a net profit margin of -296.76%.

Official website: gbs.inc

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides